Quantcast
Channel: Latest Crohn's Disease News on BioPortfolio
Viewing all articles
Browse latest Browse all 2985

TiGenix Takeda Exercises its Option to Develop and Commercialize Cx601 in both Japan and Canada

$
0
0
PRESS RELEASE REGULATED INFORMATION INSIDE INFORMATION Takeda Exercises its Option to Develop and Commercialize Cx601 in both Japan and Canada Leuven BELGIUM December 21 2016 2201h CET TiGenix NV Euronext Brussels and Nasdaq TIG; the "Compan...

Viewing all articles
Browse latest Browse all 2985

Trending Articles